Principal Investigator
Jaime Martinez Martinez
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230686
Clinical Trial Summary
A Phase 3, Multi-Center, Randomized, Parallel, Double Masked,
Placebo-Controlled Clinical Study to Assess the Safety and
Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment
of Neurotrophic Keratopathy (SEER-2)
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Cornea
Contact Information
Study Contact
Marlene Perez
Phone Number
+1 (305) 4824309
Email
mcolon@miami.edu